Literature DB >> 1638773

Severe malaria in Gambian children is not due to lack of previous exposure to malaria.

O A Erunkulu1, A V Hill, D P Kwiatkowski, J E Todd, J Iqbal, K Berzins, E M Riley, B M Greenwood.   

Abstract

The reasons why only a small proportion of African children infected with Plasmodium falciparum develop severe or fatal malaria are not known. One possible reason is that children who develop severe disease have had less previous exposure to malaria infection, and hence have less acquired immunity, than children who develop a mild clinical attack. To investigate this possibility we have measured titres of a wide range of anti-P. falciparum antibodies in plasma samples obtained from children with severe malaria, children with mild malaria and from children with other illnesses. Mean antibody levels in patients with malaria were higher than those in patients with other conditions but, with only one exception, there were no significant differences in antibody titres between cases of severe or mild malaria. A parasitized-erythrocyte agglutination assay was used to estimate the diversity of parasite isolates to which children had been exposed; plasma samples obtained from children with cerebral malaria recognized as many isolates as did samples obtained from children with mild disease. Our findings do not provide any support for the view that the development of severe malaria in a small proportion of African children infected with P. falciparum is due to lack of previous exposure to the infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638773      PMCID: PMC1554452          DOI: 10.1111/j.1365-2249.1992.tb06948.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Impairment of Plasmodium falciparum-specific antibody response in severe malaria.

Authors:  P Brasseur; J J Ballet; P Druilhe
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Immunological evaluation of cell-mediated and humoral immunity in Thai patients with cerebral and non cerebral Plasmodium falciparum malaria: II. Evolution of serum levels of immunoglobulins, antimalarial antibodies, complement fractions and alpha interferon.

Authors:  A Fribourg-Blanc; P Druilhe; P Brasseur; A Rhodes-Feuillette; J J Ballet; S Tharavanij
Journal:  Southeast Asian J Trop Med Public Health       Date:  1985-06       Impact factor: 0.267

3.  Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants.

Authors:  K Marsh; R J Howard
Journal:  Science       Date:  1986-01-10       Impact factor: 47.728

4.  Why do some African children develop severe malaria?

Authors:  B Greenwood; K Marsh; R Snow
Journal:  Parasitol Today       Date:  1991-10

5.  Common west African HLA antigens are associated with protection from severe malaria.

Authors:  A V Hill; C E Allsopp; D Kwiatkowski; N M Anstey; P Twumasi; P A Rowe; S Bennett; D Brewster; A J McMichael; B M Greenwood
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

6.  Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes.

Authors:  F Sinigaglia; B Takacs; H Jacot; H Matile; J R Pink; A Crisanti; H Bujard
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

7.  Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies.

Authors:  J Carlson; H Helmby; A V Hill; D Brewster; B M Greenwood; M Wahlgren
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321

8.  Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.

Authors:  G Del Giudice; H D Engers; C Tougne; S S Biro; N Weiss; A S Verdini; A Pessi; A A Degremont; T A Freyvogel; P H Lambert
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

Review 9.  Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components.

Authors:  H Perlmann; P Perlmann; K Berzins; B Wåhlin; M Troye-Blomberg; M Hagstedt; I Andersson; B Högh; E Petersen; A Björkman
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

10.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

Authors:  H Perlmann; K Berzins; M Wahlgren; J Carlsson; A Björkman; M E Patarroyo; P Perlmann
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Host-parasite interaction and morbidity in malaria endemic areas.

Authors:  K Marsh; R W Snow
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

2.  Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria.

Authors:  J L Sarthou; G Angel; G Aribot; C Rogier; A Dieye; A Toure Balde; B Diatta; P Seignot; C Roussilhon
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Acquired immunity and postnatal clinical protection in childhood cerebral malaria.

Authors:  S Gupta; R W Snow; C Donnelly; C Newbold
Journal:  Proc Biol Sci       Date:  1999-01-07       Impact factor: 5.349

4.  Health care related factors associated with severe malaria in children in Kampala, Uganda.

Authors:  P Byakika-Kibwika; G Ndeezi; M R Kamya
Journal:  Afr Health Sci       Date:  2009-09       Impact factor: 0.927

5.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

6.  Parasite burden and severity of malaria in Tanzanian children.

Authors:  Bronner P Gonçalves; Chiung-Yu Huang; Robert Morrison; Sarah Holte; Edward Kabyemela; D Rebecca Prevots; Michal Fried; Patrick E Duffy
Journal:  N Engl J Med       Date:  2014-05-08       Impact factor: 91.245

Review 7.  The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.

Authors:  K Artavanis-Tsakonas; J E Tongren; E M Riley
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions.

Authors:  J Iqbal; P Perlmann; B M Greenwood; K Berzins
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

9.  Parasite virulence and disease patterns in Plasmodium falciparum malaria.

Authors:  S Gupta; A V Hill; D Kwiatkowski; A M Greenwood; B M Greenwood; K P Day
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 10.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.